Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.
企業コードMRK
会社名Merck & Co Inc
上場日Feb 06, 2077
最高経営責任者「CEO」Davis (Robert M)
従業員数75000
証券種類Ordinary Share
決算期末Feb 06
本社所在地126 East Lincoln Avenue
都市RAHWAY
証券取引所NASDAQ OMX NASDAQ Basic NYSE
国United States of America
郵便番号07065
電話番号19087404000
ウェブサイトhttps://www.merck.com/
企業コードMRK
上場日Feb 06, 2077
最高経営責任者「CEO」Davis (Robert M)